News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
TURKEL CATHERINE C.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/27/2023 |
4
| TURKEL CATHERINE C. (Director) has filed a Form 4 on Lexaria Bioscience Corp.|
Txns:
| Bought 1,500 shares
@ $2.8446, valued at
$4.3k
|
|
| 10/13/2022 |
4
| TURKEL CATHERINE C. (Director) has filed a Form 4 on Lexaria Bioscience Corp.|
Txns:
| Granted 1,600 options
@ $1.96, valued at
$3.1k
|
|
| 09/06/2022 |
4
| TURKEL CATHERINE C. (Director) has filed a Form 4 on Lexaria Bioscience Corp.|
Txns:
| Granted 3,400 options
@ $3.04, valued at
$10.3k
|
|
| 09/06/2022 |
3
| TURKEL CATHERINE C. (Director) has filed a Form 3 on Lexaria Bioscience Corp. |
| 03/20/2020 |
4
| TURKEL CATHERINE C. (President) has filed a Form 4 on Novus Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $0.26, valued at
$26k
|
|
| 09/30/2019 |
4
| TURKEL CATHERINE C. (President) has filed a Form 4 on Novus Therapeutics, Inc.|
Txns:
| Granted 75,000 options to buy
@ $0.67, valued at
$50.3k
|
|
| 05/22/2019 |
4
| TURKEL CATHERINE C. (President) has filed a Form 4 on Novus Therapeutics, Inc.|
Txns:
| Sold 7,623 shares
@ $1.9616, valued at
$15k
Sold 1,914 shares
@ $1.9114, valued at
$3.7k
|
|
| 03/18/2019 |
4
| TURKEL CATHERINE C. (President) has filed a Form 4 on Novus Therapeutics, Inc.|
Txns:
| Granted 20,000 shares
@ $0
Granted 50,000 options to buy
@ $3.72, valued at
$186k
|
|
| 09/13/2018 |
4
| TURKEL CATHERINE C. (President) has filed a Form 4 on Novus Therapeutics, Inc.|
Txns:
| Bought 17,048 shares
@ $4.556, valued at
$77.7k
Bought 16,632 shares
@ $5.019, valued at
$83.5k
|
|
| 09/07/2018 |
4
| TURKEL CATHERINE C. (President) has filed a Form 4 on Novus Therapeutics, Inc.|
Txns:
| Bought 805 shares
@ $3.966, valued at
$3.2k
|
|
| 03/15/2018 |
4
| TURKEL CATHERINE C. (President) has filed a Form 4 on Novus Therapeutics, Inc.|
Txns:
| Granted 20,000 shares
@ $0
Granted 24,000 options to buy
@ $4.83, valued at
$115.9k
|
|
| 11/06/2017 |
4
| TURKEL CATHERINE C. (President) has filed a Form 4 on Novus Therapeutics, Inc.|
Txns:
| Granted 50,000 options to buy
@ $4.21, valued at
$210.5k
|
|
| 05/26/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/11/2017 |
4
| TURKEL CATHERINE C. (Chief Development Officer) has filed a Form 4 on Novus Therapeutics, Inc.|
Txns:
| Bought 11,111 shares
@ $9.99, valued at
$111k
|
|
| 05/11/2017 |
3
| TURKEL CATHERINE C. (Chief Development Officer) has filed a Form 3 on Novus Therapeutics, Inc. |
|
|